Funding

Pending

NIH R21 (PI: Keith Cheng, Pathology PSU COM). Tissue-, Cell-, and Gene-specific Probes for X-Ray Histotomography. Award Period: 2 years.


Incoming

NIH/Office of the Director R24, Competitive Renewal (PI: Keith Cheng, Pathology PSU COM; Co-I Patrick La Riviere, University of Chicago). Groundwork for a Synchrotron Micro-CT Imaging Resource for Biology. Award Period: 2019-2022. Awarded


Current

NIH R01 (PI: Yongsoo Kim, Neural and Behavioral Sciences PSU COM; Co-I: Keith Cheng, Pathology PSU COM, Co-I: Patrick Drew, Engineering Science and Mechanics PSU). Understanding Cellular Architecture of the Neurovascular Unit and its Function in the Whole Mouse Brain. Award Period: 2018-2023.

NIH R01 (PI: Yongsoo Kim, Neural and Behavioral Sciences PSU COM; Co-I: Keith Cheng, Pathology PSU COM). Brain-wide Input and Output Wiring Diagram of Oxytocin Neurons and its Function in Claustrum-endopiriform Complex. Award Period: 2018-2023.

NIH/Office of the Director R24 (PI: Keith Cheng, Pathology PSU COM; Co-I Patrick La Riviere, University of Chicago). Groundwork for a Synchrotron Micro-CT Imaging Resource for Biology. Award Period: 2015-2019.

Penn State Institute for Cyberscience (PI: Keith Cheng, Pathology PSU COM). Creation of a Penn State Consortium for Interdisciplinary Image Informatics and Visualization. Award Period: 2016-2020.

Commonwealth Universal Research Enhancement (CURE) Program Grant (PI: Keith Cheng, Pathology PSU COM; Co-PI: Khai Chung Ang, Pathology PSU COM). Digital Environmental Monitoring. Award Period: 2018-2019.

The Jake Gittlen Laboratories for Cancer Research, Penn State College of Medicine, Hershey, United States